$UDN
INVESCO DB US DOLLAR INDEX BEARISH FUND

2024 Q3 Form 10-Q Financial Statement

#000095017024122600 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $724.6K
YoY Change -23.84%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $107.9K
YoY Change -24.03%
Operating Profit $622.4K
YoY Change -23.96%
Interest Expense $1.167K
YoY Change -37.93%
% of Operating Profit 0.19%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $2.998M
YoY Change -268.48%
Net Earnings / Revenue 413.74%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 3.350M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $73.47M
YoY Change 15.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $10.08M
YoY Change 22160.37%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.38M
YoY Change
Total Liabilities & Shareholders Equity $73.47M
YoY Change 15.77%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $2.998M
YoY Change -268.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001383149
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33318
dei Entity Registrant Name
EntityRegistrantName
INVESCO DB US DOLLAR INDEX BEARISH FUND
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778084
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Invesco Capital Management LLC
dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
983-0903
dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
dei Trading Symbol
TradingSymbol
UDN
dei Security Exchange Name
SecurityExchangeName
NYSEArca
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3350000
CY2024Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
39593082
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
29517982
CY2024Q3 us-gaap Dividends Receivable
DividendsReceivable
123646
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
160805
CY2024Q3 us-gaap Assets
Assets
73466814
CY2023Q4 us-gaap Assets
Assets
65524960
CY2024Q3 udn Payable To Clearing Organizations
PayableToClearingOrganizations
257912
CY2023Q4 udn Payable To Clearing Organizations
PayableToClearingOrganizations
73312
CY2024Q3 udn Payables For Investments Purchased
PayablesForInvestmentsPurchased
9786908
CY2024Q3 us-gaap Management Fee Payable
ManagementFeePayable
34346
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
38132
CY2024Q3 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
5002
CY2023Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
5001
CY2024Q3 us-gaap Liabilities
Liabilities
10084168
CY2023Q4 us-gaap Liabilities
Liabilities
116445
CY2024Q3 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
757
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
737
CY2024Q3 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
63381889
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
65407778
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
63382646
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
65408515
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73466814
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65524960
CY2024Q3 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2023Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2024Q3 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3350000
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3550000
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.92
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.42
CY2024Q3 udn Market Value Per Share
MarketValuePerShare
18.93
CY2023Q4 udn Market Value Per Share
MarketValuePerShare
18.43
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
73321358
CY2024Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.1571
CY2024Q3 udn Investments In Securities
InvestmentsInSecurities
73343168
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
65341449
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9993
CY2023Q4 udn Investments In Securities
InvestmentsInSecurities
65364155
CY2024Q3 us-gaap Interest Income Operating
InterestIncomeOperating
395381
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
475171
us-gaap Interest Income Operating
InterestIncomeOperating
1189064
us-gaap Interest Income Operating
InterestIncomeOperating
1489615
CY2024Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
329188
CY2023Q3 us-gaap Dividend Income Operating
DividendIncomeOperating
476170
us-gaap Dividend Income Operating
DividendIncomeOperating
1137870
us-gaap Dividend Income Operating
DividendIncomeOperating
1488559
CY2024Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
724569
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
951341
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2326934
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2978174
CY2024Q3 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
103918
CY2023Q3 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
136609
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
330339
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
462545
CY2024Q3 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
2800
CY2023Q3 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
3522
us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
8448
us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
12030
CY2024Q3 us-gaap Interest Expense
InterestExpense
1167
CY2023Q3 us-gaap Interest Expense
InterestExpense
1880
us-gaap Interest Expense
InterestExpense
4269
us-gaap Interest Expense
InterestExpense
6333
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
107885
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
142011
us-gaap Operating Expenses
OperatingExpenses
343056
us-gaap Operating Expenses
OperatingExpenses
480908
CY2024Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
5734
CY2023Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
9221
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
20480
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
29423
CY2024Q3 udn Operating Expenses Net
OperatingExpensesNet
102151
CY2023Q3 udn Operating Expenses Net
OperatingExpensesNet
132790
udn Operating Expenses Net
OperatingExpensesNet
322576
udn Operating Expenses Net
OperatingExpensesNet
451485
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
622418
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
818551
us-gaap Operating Income Loss
OperatingIncomeLoss
2004358
us-gaap Operating Income Loss
OperatingIncomeLoss
2526689
CY2024Q3 udn Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
1532903
CY2023Q3 udn Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
-2081894
udn Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
-202691
udn Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
-2404060
CY2024Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1532903
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2081894
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-202691
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2404060
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
18728
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-4305
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-896
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-7833
CY2024Q3 udn Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
823753
CY2023Q3 udn Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-511682
udn Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-602564
udn Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-1175815
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
842481
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-515987
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-603460
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1183648
CY2024Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
2375384
CY2023Q3 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-2597881
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-806151
us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-3587708
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2997802
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1779330
us-gaap Net Income Loss
NetIncomeLoss
1198207
us-gaap Net Income Loss
NetIncomeLoss
-1061019
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
52799983
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10313527
CY2024Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2728666
CY2024Q3 udn Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
7584861
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
622418
CY2024Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
1532903
CY2024Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
842481
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
2997802
CY2024Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
10582663
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
63382646
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
71549741
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7597367
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
13952247
CY2023Q3 udn Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-6354880
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
818551
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-2081894
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-515987
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1779330
CY2023Q3 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-8134210
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
63415531
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
65408515
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13017910
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
16241986
udn Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-3224076
us-gaap Operating Income Loss
OperatingIncomeLoss
2004358
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-202691
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-603460
us-gaap Net Income Loss
NetIncomeLoss
1198207
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-2025869
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
63382646
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99877740
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
43377503
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
78778693
udn Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-35401190
us-gaap Operating Income Loss
OperatingIncomeLoss
2526689
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-2404060
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-1183648
us-gaap Net Income Loss
NetIncomeLoss
-1061019
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-36462209
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
63415531
us-gaap Net Income Loss
NetIncomeLoss
1198207
us-gaap Net Income Loss
NetIncomeLoss
-1061019
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
34103019
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
105488236
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
35000000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
103000000
udn Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
27043421
udn Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
84203117
udn Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
29139508
udn Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
123815423
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-1186069
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-1484444
udn Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-896
udn Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-7833
udn Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-184600
udn Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-228337
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-37159
us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-38326
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-3786
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-16177
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
1
us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-148
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3224076
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34836778
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13017910
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43377503
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16241986
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
78778693
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3224076
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35401190
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-564412
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
564412
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
us-gaap Interest Paid Net
InterestPaidNet
4269
us-gaap Interest Paid Net
InterestPaidNet
6333
CY2024Q3 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
udn Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
udn Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
udn Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">B. Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span></p>
us-gaap Distributed Earnings
DistributedEarnings
0
us-gaap Distributed Earnings
DistributedEarnings
0
CY2024Q3 us-gaap Distributed Earnings
DistributedEarnings
0
CY2023Q3 us-gaap Distributed Earnings
DistributedEarnings
0
udn Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5
CY2024Q3 udn Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5
CY2023Q3 udn Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5
udn Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5
CY2024Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
5734
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
20480
CY2023Q3 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
9221
us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
29423
us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5 – Deposits with Commodity Broker and Custodian</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund defines cash as cash held by the Custodian. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cash equivalents held by the Fund as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2024 and December 31, 2023. The Fund considers investments in money market funds to be investments in securities and, accordingly, includes them in its Schedule of Investments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the currency futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Due to custodian.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because the Fund’s assets are maintained with the Commodity Broker and Custodian, the distress, impairment or failure of the Commodity Broker or Custodian could result in the loss of or delay in access to Fund assets.</span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2024Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
39593082
CY2024Q3 udn Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
33750086
CY2024Q3 udn Investments In Securities
InvestmentsInSecurities
73343168
CY2024Q3 udn Investment Owned Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrealizedAppreciationDepreciationNet
380315
CY2024Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
73723483
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
29517982
CY2023Q4 udn Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
35846173
CY2023Q4 udn Investments In Securities
InvestmentsInSecurities
65364155
CY2023Q4 udn Investment Owned Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrealizedAppreciationDepreciationNet
982879
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
66347034
udn Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
udn Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
50000
udn Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
udn Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
50000
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.9
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.83
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.42
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.5
CY2024Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.81
CY2023Q3 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.66
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.12
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.7
CY2024Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.21
CY2023Q3 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.21
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.62
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.58
CY2024Q3 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.02
CY2023Q3 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.45
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.5
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.12
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.92
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.38
CY2024Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.92
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
18.38
CY2024Q2 udn Market Value Per Share
MarketValuePerShare
17.9
CY2023Q2 udn Market Value Per Share
MarketValuePerShare
18.82
CY2023Q4 udn Market Value Per Share
MarketValuePerShare
18.43
CY2022Q4 udn Market Value Per Share
MarketValuePerShare
18.5
CY2024Q3 udn Market Value Per Share
MarketValuePerShare
18.93
CY2023Q3 udn Market Value Per Share
MarketValuePerShare
18.37
CY2024Q3 udn Market Value Per Share
MarketValuePerShare
18.93
CY2023Q3 udn Market Value Per Share
MarketValuePerShare
18.37
CY2024Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0449
CY2023Q3 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.045
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0455
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0411
CY2024Q3 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0074
CY2023Q3 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0073
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0073
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0073
CY2024Q3 udn Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2023Q3 udn Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
udn Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
udn Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2024Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.057
CY2023Q3 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0239
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0271
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0065
CY2024Q3 udn Return At Market Value
ReturnAtMarketValue
0.0575
CY2023Q3 udn Return At Market Value
ReturnAtMarketValue
-0.0239
udn Return At Market Value
ReturnAtMarketValue
0.0271
udn Return At Market Value
ReturnAtMarketValue
-0.007
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
udn Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
udn Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122600-index-headers.html Edgar Link pending
0000950170-24-122600-index.html Edgar Link pending
0000950170-24-122600.txt Edgar Link pending
0000950170-24-122600-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img42477940_0.jpg Edgar Link pending
img42477940_1.jpg Edgar Link pending
img42477940_2.jpg Edgar Link pending
img42477940_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
udn-20240930.htm Edgar Link pending
udn-20240930.xsd Edgar Link pending
udn-ex31_1.htm Edgar Link pending
udn-ex31_2.htm Edgar Link pending
udn-ex31_3.htm Edgar Link pending
udn-ex31_4.htm Edgar Link pending
udn-ex32_1.htm Edgar Link pending
udn-ex32_2.htm Edgar Link pending
udn-ex32_3.htm Edgar Link pending
udn-ex32_4.htm Edgar Link pending
udn-20240930_htm.xml Edgar Link completed